Custom Search

FDA Information

In 2004, the U.S. Food and Drug Administration (FDA) approved Cardizem LA® (ditiazem) for the treatment of chronic stable angina.

Cardizem LA® had also been earlier approved for the treatment of high blood pressure or hypertension and is a long acting extended-release formulation of diltiazem HCl.

 

Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose

Use of this site is subject to the following terms of use